Login

GHP Specialty Care Presentation - Daniel Ohman, CEO, GHP Specialty Care AB (publ) 00:00:00

Share On Facebook Share On Twitter

GHP Specialty Care - Presentation

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Michel Vermette Discusses Armstrong Flooring's Strategic Rebuilding and Optimistic Outlook for 2021
00:00:00
Jonas Ekblom, CEO of Promore Pharma
00:10:00
Identify and evaluate investment opportunities|Amy Duffuor,Managing Director,Prime Impact Fund
00:00:00
Paradigm Biopharma – executive interview - Paul Rennie, CEO, co-founder and chairman, Paradigm Biopharmaceuticals Ltd
00:00:00
Richard O. White, M.D.Pediatrician
00:10:00
The benefits for startups to raise funds from celebrity investors such as American actor|Keisuke Honda,Co-Founder,Dreamers VC
00:10:00
Richard Carleton CEO of the Canadian Securities Exchange
00:10:00
From Door-to-Door Sales to Leading Angi’s Home Services Revolution | Angie Hicks, Co-Founder, Angi Inc.
00:10:00
"Investing 101: Brendan Caldwell's Guide for Millennials and Gen Z"
00:10:00
Glenn Milnes, CEO of IkeGPS Group Limited, discusses the company's ambition to establish itself as the industry standard for collecting, analyzing, and managing pole and overhead asset information for utility and communication sectors during the ASX Small
00:10:00
Investor Insights: Real Estate, Infrastructure, and Renewable Trends | Bruce Flatt, CEO,Brookfield Asset Management.
00:10:00
Simona Grossi, CEO of Greenthesis Spa, leads an industrially evolving group committed to sustainability and innovation.

© 2026 Nehu